IMRX
#3234
Immuneering Corporation - Class A Common Stock
5.1 6 USD
+0.01%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+0.98%
Variación mensual
+20.56%
Variación en los últimos 6 meses
+15.70%
Cambio anual
+23.15%
Cierres anteriores
5.1 1
Open
5.1 6
Mínimo
5.1 6
High
5.1 6
Volumen
84
Financials
- Market Capitalization 333.84 M
- Employee 55
- Founded 2008
- CEO N/A
- Website www.immuneering.com
- Headquarter Delaware, United States
- FIGI BBG009QXJQS1
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-5.18
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3228 |  CTNM Contineum Therapeutics, Inc. - Common stock | 14.62 USD | -3.75% | -2.21% | +20.53% | -4.26% | 337.71 M USD | ||
| 3232 |  LYEL Lyell Immunopharma, Inc. - Common Stock | 14.33 USD | -4.53% | +2.65% | +3.99% | -40.76% | 334.38 M USD | ||
| 3249 |  ZNTL Zentalis Pharmaceuticals, Inc. - common stock | 4.62 USD | -5.33% | -1.49% | +19.07% | +237.23% | 328.88 M USD | ||
| 3252 |  PALI Palisade Bio, Inc. - Common Stock | 1.89 USD | -3.57% | -12.90% | +9.25% | +11.18% | 328.07 M USD |